Medicare expert. Deputy Director, Program on Medicare Policy @KFF Part D, prescription drug policy, Medicare spending & financing, cyclist, NYT spelling bee fan
Apr 26, 2022 • 8 tweets • 5 min read
1/ I’m excited to unveil our new @KFF interactive on #Medicare spending.
We do a deep dive on enrollment growth, spending trends, the expanding role of #MedicareAdvantage, Part A trust fund solvency & more.
Here's a quick look at what's inside: kff.org/interactive/me…2/ #Medicare now covers 65 million older adults and younger people with disabilities, or about 1 in 5 Americans. Its size and importance often make it a big part of federal budget and health care spending discussions.
By 2060, enrollment is expected to grow to 93 million people.
Mar 11, 2020 • 12 tweets • 3 min read
In non-coronavirus news, @CMSGov has announced a new voluntary innovation center model starting in 2021 that would allow participating Part D plans to offer coverage of insulin for a flat monthly copayment of no more than $35. innovation.cms.gov/initiatives/pa…
Some thoughts on the model...
Participating Part D plans – enhanced plans only, not basic plans – can offer insulin products from participating manufacturers at a flat $35 copay during all phases of the benefit (deductible, initial coverage, coverage gap, and catastrophic).